Systemic and bronchial inflammation following LPS inhalation in asthmatic and healthy subjects

Journal of Endotoxin Research

Volumn 12, Issue 6, 2006, Pages 367-374

  Kitz, Richard ^a   Rose, Markus A ^a   Borgmann, Alexandra ^a   Schubert, Ralf ^a   Zielen, Stefan ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Endotoxin; Exhaled nitric oxide; Inflammation; Lung function

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; EOSINOPHIL CATIONIC PROTEIN; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; NITRIC OXIDE; THROMBOXANE B2; BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LEUKOTRIENE;

ADULT; ARTICLE; ASTHMA; BODY TEMPERATURE; BRONCHITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; PROVOCATION TEST; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; BLOOD; BODY SIZE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EOSINOPHIL; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE; METABOLISM; MITE; NEUTROPHIL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADMINISTRATION, INHALATION; ADULT; ANIMALS; ASTHMA; BIOLOGICAL MARKERS; BODY SIZE; BODY WEIGHT; C-REACTIVE PROTEIN; EOSINOPHILS; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTES; LEUKOTRIENE B4; LEUKOTRIENES; LIPOPOLYSACCHARIDES; MALE; MITES; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE III; REFERENCE VALUES;

EID: 34047129810     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805106X153934     Document Type: Article

References (38)

1. Rylander R., Haglind P., Lundholm M. Endotoxin in cotton dust and respiratory function decrement among cotton workers in an experimental cardroom. Am Rev Respir Dis 1985; 131: 209-213.
2. Smid T., Heederik D., Houba R. et al. Dust-and endotoxin-related respiratory effects in the animal feed industry. Am Rev Respir Dis 1992; 146: 1474-1479.
3. Fearon DT, Locksley RM The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-53.
4. Medzhitov R., Janeway Jr CA. Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol 1997;9: 4-9.
5. Boehlecke B., Hazucha M., Alexis NE et al. Low-dose airborne endotoxin exposure enhances bronchial responsiveness to inhaled allergen in atopic asthmatics. J Allergy Clin Immunol 2003; 112: 1241-1243.
6. Rylander R., Bake B., Fischer JJ et al. Pulmonary function and symptoms after inhalation of endotoxin. Am Rev Respir Dis 1989; 140: 981-986.
7. Michel O., Duchateau J., Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol 1989; 66: 1059-1066.
8. Michel O., Kips J., Duchateau J. et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154: 1641-1646.
9. Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res 2003; 9: 293-300.
10. Kline JN, Cowden JD, Hunninghake GW et al. Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med 1999; 160: 297-303.
11. Michel O., Nagy AM, Schroeven M. et al. Dose-response relationship to inhaled endotoxin in normal subjects. Am J Respir Crit Care Med 1997; 156: 1157-1164.
12. Michel O., Dentener M., Corazza F. et al. Healthy subjects express differences in clinical responses to inhaled lipopolysaccharide that are related with inflammation and with atopy. J Allergy Clin Immunol 2001; 107: 797-804.
13. Franklin PJ, Stick SM, Le Souef PN et al. Measuring exhaled nitric oxide levels in adults. The importance of atopy and airway responsiveness. Chest 2004; 126: 1540-2545.
14. Ho LP, Wood FT, Robson A. et al. Atopy influences exhaled nitric oxide levels in adult asthmatics. Chest 2000; 118: 1327-1331.
15. Piipari R., Piirila P., Keskinen H. et al. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur Respir J 2002; 20: 1532-1537.
16. Stitt JT, Dubois AB, Douglas JS et al. Exhalation of gaseous nitric oxide by rats in response to endotoxin and its absorption by the lungs. J Appl Physiol 1997; 82: 305-316.
17. Moncada S., Plamer RM, Higgs EA Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
18. Rolla G., Bucca C., Brussino L. et al. Pentoxifylline attenuates LPS-induced bronchial hyperresponsiveness but not the increase in exhaled nitric oxide. Clin Exp Allergy 1997; 27: 96-103.
19. Sundblad BM, Larsson BM, Palmberg L. et al. Exhaled nitric oxide and bronchial responsiveness in healthy subjects exposed to organic dust. Eur Respir J 2002; 20: 426-431.
20. VanderMeer TJ, Menconi MJ, O'Sullivan BP et al. Acute lung injury in endotoxemic pigs: Role of leukotriene B4. J Appl Physiol 1995; 78:1121-1131.
21. Uhlig S., Nusing R., von Bethmann A. et al. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol Med 1996; 2: 373-383.
22. Alving K., Weitzberg E., Lundberg JM Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368-1370.
23. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurements of exhaled lower respiratory nitric oxide and nasal oxide in adults and children. Am J Respir Crit Care Med 1999; 160: 2104-2117.
24. Wang D., Wei J., Hsu K. et al. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats. J Biomed Sci 1999; 6: 28-35.
25. Okamoto T., Gohil K., Finkelstein EI et al. A multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol 2004; 286 (1): L198-L209.
26. Lee RP, Wang D., Kao Sju et al. The lung is the major site that produces nitric oxide to induce acute pulmonary edema in endotoxin shock. Clin Exp Pharm Physiol 2001; 28: 315-320.
27. Wesselius LJ, Nelson ME, Bailey K. et al. Rapid lung cytokine accumulation and neutrophil recruitment after lipopolysaccharide inhalation by cigarette smokers and nonsmokers. J Lab Clin Med 1997; 129: 106-114.
28. Toward TJ, Broadley KJ Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation. Br J Pharmacol 2000; 131: 271-281.
29. Rylander R., Michel O. Organic dust induced inflammation-role of atopy and TLR-4 and CD14 gene polymorphisms. Am J Ind Med 2005; 48: 302-307.
30. Alba-Loureiro TC, Martins EF, Miyasaka CK et al. Evidence that arachidonic acid derived from neutrophils and prostaglandin E2 are associated with the induction of acute lung inflammation by lipopolysaccharide of Escherichia coli. Inflamm Res 2004; 53: 658-663.
31. von Aulock S., Hermann C., Hartung T. Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo. J Immunol Methods 2003; 277: 53-63.
32. Brass DM, Savov JD, Whitehead GS et al. LPS binding protein is important in the airway response to inhaled endotoxin. J Allergy Clin Immunol 2004; 114: 586-592.
33. Dentener MA, Vreugdenhil Ace, Hoet Phm et al. Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells. Am J Respir Cell Mol Biol 2000; 23: 146-153.
34. Douwes J., Pearce N., Heederik D. Does environmental endotoxin exposure prevent asthma? Thorax 2002; 57: 86-90.
35. Michel O., Duchateau J., Plat G. et al. Blood inflammatory response to inhaled endotoxin in normal subjects. Clin Exp Allergy 1995; 25: 73-79.
36. Dubin W., Martin TR, Swoveland P. et al. Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 bronchoalveolar compartment. Am J Physiol 1996; 270: L736-L744.
37. Strohmeier GR, Walsh JH, Klings ES et al. Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma. J Immunol 2001; 166: 2063-2070.
38. Piacentini GL, Bodini A., Peroni DG et al. Reduction in exhaled nitric oxide immediately after metacholine challenge in asthmatic children. Thorax 2002; 57: 771-773.